Ischemic Colitis
- Overview
- Epidemiology
- Pathophysiology
- Watershed Areas
- Risk Factors and Triggers
- Clinical Presentation
- Diagnosis
- Treatment
- Right-Colon Ischemic Colitis
- Long-Term Outlook
- Key Research Papers
- Connections
- Featured Videos
Overview
Ischemic colitis (IC) is the most common form of intestinal ischemia, accounting for approximately 50–60% of all gastrointestinal ischemic events. Unlike acute mesenteric ischemia — which involves occlusion of major mesenteric vessels with high acute mortality — ischemic colitis typically results from transient, non-occlusive reduction in mucosal blood flow, most commonly in older adults.
The colon is supplied predominantly by the superior and inferior mesenteric arteries (SMA and IMA), with the IMA territory being more vulnerable due to lower baseline flow and fewer collateral pathways. Ischemic colitis most commonly affects the left colon.
The disease spectrum ranges from self-limiting transient ischemia to fulminant transmural infarction requiring emergency colectomy. A 2017 review puts the non-gangrenous type at almost 80–85% of cases and gangrene at 15%. A 2012 review of 1,049 patients found that 19.6% needed surgery, and a Minnesota population study found 17%. A prospective Spanish study of 364 patients classed 9.9% as gangrenous colitis, 2.5% as fulminant pancolitis and 17.9% as chronic segmental colitis.
Epidemiology
- Incidence: 4.5 to 44 cases per 100,000 person-years in general populations (2004 systematic review); in Olmsted County, Minnesota, it rose from 6.1 in 1976–1980 to 22.9 in 2005–2009; substantially higher in the elderly.
- Age at presentation: median 71.6 years in the Minnesota study, mean 73 years in a 174-patient CT study; uncommon before age 50 except in specific high-risk groups.
- Female predominance that varies by study: 55.9% women in a case-control study (matched cases and controls, mean age 75.67 years) and 67% in the Minnesota study.
- Irritable bowel syndrome or chronic obstructive pulmonary disease raised the risk two- to four-fold, and the risk was also higher in women and at age 65 and older (2004 systematic review).
- Hospital-acquired IC: 0.1–1% of patients following aortic surgery; up to 2–3% after aortoiliac bypass.
- Most common gastrointestinal (GI) ischemic emergency in the United States, accounting for 1 in 1,000 hospital admissions.
- Misdiagnosis is common early: often confused with inflammatory bowel disease or infectious colitis.
Pathophysiology
Unlike acute mesenteric ischemia (which requires immediate vascular intervention), ischemic colitis results from temporary reduction in blood flow — typically non-occlusive:
- Reduced cardiac output (heart failure, sepsis, hemorrhagic shock)
- Vasospasm (medications, cocaine, catecholamines)
- Small-vessel disease (atherosclerosis, diabetes, hypertension)
- Venous outflow obstruction (rare — aortoiliac compression, hypercoagulable states)
Mucosal ischemia leads to epithelial sloughing, mucosal hemorrhage, and edema. If reperfusion occurs, recovery follows. If ischemia persists, transmural necrosis develops, leading to perforation and peritonitis.
The rectum is usually spared because of its dual blood supply (IMA via superior rectal artery + internal iliac via middle/inferior rectal arteries). Rectal ischemia suggests severe systemic hypoperfusion or pelvic vascular disease.
Watershed Areas
Two anatomical sites are disproportionately vulnerable — "watershed zones" where blood supply is most tenuous:
Splenic Flexure — Griffiths' Point
The junction between the SMA (right colic/middle colic supply) and IMA (left colic supply). Limited collateral overlap at this point makes the splenic flexure the classic site of ischemic colitis. Approximately 25% of all IC cases occur here.
Rectosigmoid Junction — Sudeck's Point
The transition between the IMA-supplied sigmoid colon and the hypogastric/pudendal supply of the rectum. The last sigmoidal branch of the IMA anastomoses poorly with superior rectal branches, making this second watershed another common site. Approximately 50% of cases involve the sigmoid and descending colon.
Note: right-colon IC has distinct characteristics (see dedicated section below).
Risk Factors and Triggers
Age and Vascular Conditions
- Age >60 (most important demographic risk factor)
- Atherosclerosis (peripheral vascular disease, coronary artery disease)
- Hypertension, diabetes, hyperlipidemia
- Measured links: in one case-control study, diabetes (odds ratio 1.76), dyslipidemia (2.12), heart failure (3.17) and peripheral arterial disease (4.1); in the Minnesota study, odds ratios for atherosclerotic diseases from 2.6 (coronary disease) to 7.9 (peripheral vascular disease)
Physiologic and Situational
- Hypotension (sepsis, hemorrhage, dehydration, dialysis-related)
- Major surgery (especially aortic, cardiac, colorectal)
- Constipation and constipation-predominant irritable bowel syndrome (IBS-C) (increased intraluminal pressure leading to mucosal ischemia)
- Long-distance running (splanchnic vasoconstriction during extreme exercise)
Medications and Substances
- Nonsteroidal anti-inflammatory drugs (reduce mucosal prostaglandins + direct vasoconstrictive effect)
- Constipating agents (opioids, anticholinergics, calcium channel blockers)
- Triptans (potent vasoconstrictors — triptan-induced IC well-documented)
- Cocaine (intense splanchnic vasoconstriction)
- Alosetron (5-HT3 antagonist for diarrhea-predominant irritable bowel syndrome (IBS-D) — carries a black box warning for IC)
- Interferon (vasoactive effects)
- Hormonal contraceptives (thrombotic + vasospastic risk)
- Digoxin (splanchnic vasoconstriction at high doses; a 2017 review lists digitalis among vasoconstrictive agents; in the 2010 case-control study its odds ratio was 0.27, below 1, although that paper's conclusion lists it among associated factors)
- Aspirin (odds ratio 1.97 in the same case-control study)
Case reports from 2026 describe ischemic colitis in people taking glucagon-like peptide-1 weight-loss and diabetes drugs: a 46-year-old woman on oral semaglutide with three episodes, the third after the drug was restarted; a 53-year-old woman on semaglutide without other illnesses; and a 32-year-old woman with no prior medical history after six weeks of tirzepatide. These are case reports and do not establish cause or how often it happens.
Clinical Presentation
Classic Triad
- Sudden onset crampy, left-sided abdominal pain
- Urgent desire to defecate
- Bright-red or maroon blood per rectum (hematochezia) — usually within 24 hours of pain onset
Key Features
- Mild-to-moderate tenderness over left colon (typically non-peritoneal in early or transient disease)
- Symptoms typically appear within hours of precipitating event (e.g., hypotension, medication)
- Fever and leukocytosis may be present, particularly with transmural disease
- Abdominal distention and peritoneal signs indicate transmural necrosis — a surgical emergency
Differentiation from Acute Mesenteric Ischemia (AMI)
- IC: left-sided pain + bloody stool (hematochezia) + older patient
- AMI: periumbilical/right-sided pain + "pain out of proportion to exam" + usually no bleeding early + severe systemic illness
Signs Linked to a Worse Course
In a prospective study of 364 patients in 24 Spanish hospitals, doctors suspected the disease in only 24.2% of cases. Surgery or death was more likely with abdominal pain without rectal bleeding (odds ratio 3.9), non-bloody diarrhea (odds ratio 10) and peritoneal signs (odds ratio 7.3).
Diagnosis
Laboratory
- Complete blood count (CBC) (leukocytosis), comprehensive metabolic panel (creatinine), blood lactate, coagulation, type-and-screen
- Serum lactate: elevated in transmural/necrotic disease; normal in mild IC
- Stool cultures + Clostridioides difficile polymerase chain reaction (PCR): to exclude infectious colitis (important differential)
Computed Tomography Abdomen and Pelvis with Contrast — Usually First-Line
- Bowel wall thickening of the affected segment (most sensitive finding)
- Pericolonic fat stranding
- "Thumbprinting" — submucosal edema creating a scalloped pattern on plain film
- Pneumatosis coli or portal venous gas: signs of transmural necrosis — surgical emergency
Colonoscopy — Diagnostic Gold Standard (When Safe)
- Not done when signs of peritonitis, perforation, or gangrene are present
- Usually done within 48 hours of presentation (after surgical exclusion)
- Findings: segmental mucosal hemorrhage, edema, erosions, ulcerations; the "colon single-stripe sign" (a single linear ulcer along the length of the colon) is linked to ischemia rather than unique to it: in a study of 26 patients, 75% had microscopic ischemic injury and 62% a preceding ischemic event. It seems to mark milder disease: none of those patients needed surgery, against 27% of 22 patients with ischemia around the whole circumference
- Biopsy: ghost cells (ischemic enterocytes), crypt withering, fibrin thrombi in lamina propria
Predictors reported in published reviews and studies: a 2016 review of 2,823 patients from 22 studies named right-sided disease, peritonitis, shock or systolic pressure under 90 mmHg, male sex, a fast heart rate and lack of rectal bleeding. The Montpellier CT severity score reached 68% sensitivity and 81% specificity in 174 patients.
Across 132,455 US admissions from 2017 to 2022, colonoscopy was done in 42.0%, and in 72.4% of those with a recorded procedure day it was done within 48 hours. Use fell with illness severity, from 43.3% in the least sick group to 14.7% in the sickest.
Treatment
Mild-to-Moderate (Non-Transmural) — Supportive
- Nothing by mouth + intravenous fluids (to correct the low blood pressure or dehydration driving the ischemia)
- Broad-spectrum intravenous (IV) antibiotics (e.g., ciprofloxacin + metronidazole or piperacillin-tazobactam) — used empirically to reduce bacterial translocation, though randomized controlled trial (RCT) evidence is limited, and the papers read for this page do not test antibiotics in mild disease specifically
- Care described includes improving cardiac output and stopping suspected medications (nonsteroidal anti-inflammatory drugs (NSAIDs), triptans, constipating agents)
- Serial abdominal exams every 4–6 hours for the first 24–48 hours
- Bowel rest, with diet advanced slowly as symptoms resolve
- Expected course: clinical improvement within 24–48 hours; colonoscopic healing within 2 weeks in most patients
- Outcomes in a 2012 systematic review of 1,049 patients: medical care in 80.3%, of whom 6.2% died; surgery in 19.6%, of whom 39.3% died; overall mortality 12.7%
Hospitalization Indications
- Any hematochezia + abdominal pain in appropriate clinical context
- Elderly, hemodynamically unstable, or immunocompromised patients
- Right-colon involvement
Surgical Indications — Emergency Colectomy
- Peritonitis or pneumoperitoneum (perforation)
- Transmural gangrene (pneumatosis coli + portal venous gas on computed tomography, CT)
- Failure to improve clinically after 2–3 weeks of conservative therapy
- Symptomatic stricture (late complication at 3–6 months)
- IC in a patient requiring urgent vasopressors/inotropes
Follow-up colonoscopy at 2 weeks confirms healing versus persistence or stricture formation.
Right-Colon Ischemic Colitis
The share of right-colon cases differs by study: 71 of 273 biopsy-proven cases (26.0%) were isolated to the right side in one hospital series, while a national study in Iceland found 88% in the left colon. Right-colon disease carries disproportionately higher morbidity:
- Associated with the superior mesenteric artery (SMA) territory — the same vessel involved in acute mesenteric ischemia
- A 2017 review describes severe abdominal pain, rarely with bloody diarrhea, and maroon loose stool rather than the bright red blood usual in left-colon disease
- AMI is looked for with computed tomography angiography
- Higher need for surgery: 54.9% vs. 10.9% of other ischemic colitis in that hospital series
- Higher mortality: 22.5% vs. 11.9% in the same series
- Surgery or death: 40.9% vs. 10.3% in the Spanish study of 364 patients, and 48.4% vs. 12.1% in the 2016 review; a 2012 review concluded that right-sided disease "appeared to be the most significant predictor of outcome"
- Often associated with underlying hypercoagulable states or aortic pathology
- A prothrombotic workup is described as part of the evaluation in younger patients
Long-Term Outlook
In Olmsted County, Minnesota (445 cases, median age 71.6 years, 67% women), 59% of people were alive at 5 years, against 90% of matched controls. Age over 40, male sex, right-sided colon involvement, small-bowel involvement and chronic obstructive pulmonary disease were independently linked to death. In-hospital mortality was 11.5%.
Recurrence was 7.7% (11 of 142 patients) in a 10-year single-center study in Portugal, linked to smoking, coronary artery disease, prior laparotomy and clopidogrel use.
Key Research Papers
- Brandt LJ et al. "ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia." Am J Gastroenterol. 2015;110(1):18–44. — PubMed PMID: 25559486
- Cubiella Fernandez J et al. "Risk factors associated with the development of ischemic colitis." World J Gastroenterol. 2010;16(36):4564–4569. — PubMed PMID: 20857527
- Theodoropoulou A and Koutroubakis IE. "Ischemic colitis: clinical practice in diagnosis and treatment." World J Gastroenterol. 2008;14(48):7302–7308. — PubMed PMID: 19109863
- Montoro MA, Brandt LJ, Santolaria S et al. "Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)." Scand J Gastroenterol. 2011;46(2):236–246. — PubMed PMID: 20961178
- Higgins PD, Davis KJ and Laine L. "Systematic review: the epidemiology of ischaemic colitis." Aliment Pharmacol Ther. 2004;19(7):729–738. — PubMed PMID: 15043513
- Yadav S et al. "A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitis." Clin Gastroenterol Hepatol. 2015;13(4):731–738. — PubMed PMID: 25130936
- Sotiriadis J et al. "Ischemic colitis has a worse prognosis when isolated to the right side of the colon." Am J Gastroenterol. 2007;102(10):2247–2252. — PubMed PMID: 17561968
- Sun D et al. "The predictors of the severity of ischaemic colitis: a systematic review of 2823 patients from 22 studies." Colorectal Dis. 2016;18(10):949–958. — PubMed PMID: 27206727
- O'Neill S and Yalamarthi S. "Systematic review of the management of ischaemic colitis." Colorectal Dis. 2012;14(11):e751–e763. — PubMed PMID: 22776101
- Misiakos EP et al. "Advents in the Diagnosis and Management of Ischemic Colitis." Front Surg. 2017;4:47. — PubMed PMID: 28929100
- Zuckerman GR et al. "The colon single-stripe sign and its relationship to ischemic colitis." Am J Gastroenterol. 2003;98(9):2018–2022. — PubMed PMID: 14499781
- Valtchev L et al. "Assessing the severity of ischemic colitis: validation of a CT scan severity score in 174 consecutive patients." Eur Radiol. 2026;36(7):5775–5783. — PubMed PMID: 41813909
- Saji E et al. "Trends and Determinants of Inpatient Colonoscopy Use and Timing in Adults Hospitalized with Ischemic Colitis: A National Analysis, 2017-2022." Dig Dis Sci. 2026. — PubMed PMID: 42649351
- Relvas L et al. "Risk factors associated with recurrent ischemic colitis ‒ A 10-year retrospective study." Rev Esp Enferm Dig. 2026;118(8):457–465. — PubMed PMID: 41128102
- Aranda Rojas S et al. "Ischemic colitis associated with oral semaglutide with recurrence upon rechallenge." Rev Esp Enferm Dig. 2026. — PubMed PMID: 42847871
- Joma M et al. "Semaglutide-Induced Ischemic Colitis in A Middle-Aged Female Without Vascular Risk Factors." Eur J Case Rep Intern Med. 2026;13(7):006649. — PubMed PMID: 42466220
- Sekhon S, Kahlon I and Latson W. "Ischemic Colitis Associated With Tirzepatide Therapy in a Young Female Patient: A Case Report." Cureus. 2026;18(1):e101437. — PubMed PMID: 41694961
Connections
Featured Videos
Featured videos will be added shortly.